161 results on '"Quinto, Ileana"'
Search Results
2. Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α
3. Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
4. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis
5. The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis
6. Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay
7. IBtkα Activates the β-Catenin-Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3β in Cancerous B Cells
8. Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ
9. In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder
10. Metabolites Profiling of Melanoma Interstitial Fluids Reveals Uridine Diphosphate as Potent Immune Modulator Capable of Limiting Tumor Growth
11. Predictive Value of Epstein-Barr Virus Genome Copy Number and "BZLF1" Expression in Blood Lymphocytes of Transplant Recipients at Risk for Lymphoproliferative Disease
12. Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations
13. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy
14. Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes
15. Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65
16. Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
17. Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring
18. Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models
19. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice
20. Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Brutonʼs tyrosine kinase: evidence for three protein isoforms of IBtk
21. Insights into Thymus Development and Viral Thymic Infections
22. Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation
23. The aftermath of the Merck's HIV vaccine trial
24. Inhibition of HIV-1 replication in primary human monocytes by the IκB-αS32/36A repressor of NF-κB
25. Additional file 1: Table S1. of Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes
26. Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes
27. Peptide-guided targeting of GPR55 for anti-cancer therapy
28. IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells
29. Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
30. Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice
31. B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy
32. CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation
33. Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma
34. Cancer-Associated CD43 Glycoforms as Target of Immunotherapy
35. Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB
36. Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet
37. Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65
38. Mass Spectrometry-Based Identification Of The Tumor Antigen UN1 as the Transmembrane CD43 Sialoglycoprotein
39. The aftermath of the Merck's HIV vaccine trial
40. IκB-α Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export
41. High Attenuation and Immunogenicity of a Simian Immunodeficiency Virus Expressing a Proteolysis-resistant Inhibitor of NF-κB
42. Physical and Functional Interaction of HIV-1 Tat with E2F-4, a Transcriptional Regulator of Mammalian Cell Cycle
43. Predictive Value of Epstein‐Barr Virus Genome Copy Number andBZLF1Expression in Blood Lymphocytes of Transplant Recipients at Risk for Lymphoproliferative Disease
44. Potent and Stable Attenuation of Live-HIV-1 by Gain of a Proteolysis-resistant Inhibitor of NF-κB (IκB-αS32/36A) and the Implications for Vaccine Development
45. HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein β (NF-IL6) Transcription Factors
46. Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription Factors
47. An NF-κB Site in the 5′-Untranslated Leader Region of the Human Immunodeficiency Virus Type 1 Enhances the Viral Expression in Response to NF-κB-activating Stimuli
48. Regulation of NF-κB through the Nuclear Processing of p105 (NF-κB1) in Epstein-Barr Virus-immortalized B Cell Lines
49. Inhibition of HIV-1 replication in primary human monocytes by the IκB-αS32/36A repressor of NF-κB.
50. Impaired Generation of Bone Marrow B Lymphocytes in Mice Deficient in C/EBPß
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.